Works matching DE "OVARIAN cancer patients"

Results: 580

HLA class I as a predictor of clinical prognosis and CTL infiltration as a predictor of chemosensitivity in ovarian cancer.

Published in:

OncoImmunology, 2015, v. 4, n. 5, p. 0, doi. 10.1080/2162402X.2015.1005507

By:

Hirohashi, Yoshihiko;
Torigoe, Toshihiko;
Mariya, Tasuku;
Kochin, Vitaly;
Saito, Tsuyoshi;
Sato, Noriyuki

Publication type:

Article

Functional OCT4-specific CD4<sup>+</sup> and CD8<sup>+</sup> T cells in healthy controls and ovarian cancer patients.

Published in:

OncoImmunology, 2013, v. 2, n. 5, p. e24271-1, doi. 10.4161/onci.24271

By:

Jiabo Di;
Massuger, Leon F.A.G.;
Duiveman-de Boer, Tjitske;
Zusterzeel, Petra L. M.;
Figdor, Carl G.;
Torensma, Ruurd

Publication type:

Article

Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy.

Published in:

Cancer Biomarkers, 2016, v. 17, n. 1, p. 33, doi. 10.3233/CBM-160614

By:

Yi Miao;
Qin Yan;
Shuangdi Li;
Bilan Li;
Youji Feng

Publication type:

Article

IL-17A is elevated in sera of patients with poorly differentiated ovarian papillary serous cystadenocarcinoma.

Published in:

Cancer Biomarkers, 2013, v. 13, n. 6, p. 417, doi. 10.3233/CBM-140392

By:

Malekzadeh, Mahyar;
Dehaghani, Alamtaj Samsami;
Ghaderi, Abbas;
Doroudchi, Mehrnoosh

Publication type:

Article

Recruiting Cytotoxic T Cells to Folate-Receptor-Positive Cancer Cells.

Published in:

Angewandte Chemie, 2013, v. 125, n. 46, p. 12323, doi. 10.1002/ange.201306866

By:

Kularatne, Sumith A.;
Deshmukh, Vishal;
Gymnopoulos, Marco;
Biroc, Sandra L.;
Xia, Jinming;
Srinagesh, Shailaja;
Sun, Ying;
Zou, Ning;
Shimazu, Mark;
Pinkstaff, Jason;
Ensari, Semsi;
Knudsen, Nick;
Manibusan, Anthony;
Axup, Jun Y.;
Kim, Chan Hyuk;
Smider, Vaughn V.;
Javahishvili, Tsotne;
Schultz, Peter G.

Publication type:

Article

Bayesian joint analysis of heterogeneous genomics data.

Published in:

Bioinformatics, 2014, v. 30, n. 10, p. 1370, doi. 10.1093/bioinformatics/btu064

By:

Ray, Priyadip;
Zheng, Lingling;
Lucas, Joseph;
Carin, Lawrence

Publication type:

Article

Clinical Importance of Myc Family Oncogene Aberrations in Epithelial Ovarian Cancer.

Published in:

JNCI Cancer Spectrum, 2018, v. 2, n. 3, p. 1, doi. 10.1093/jncics/pky047

By:

Jung, MoonSun;
Russell, Amanda J;
Kennedy, Catherine;
Gifford, Andrew J;
Group, Australian Ovarian Cancer Study;
Mallitt, Kylie-Ann;
Sivarajasingam, Siva;
Bowtell, David D;
DeFazio, Anna;
Haber, Michelle;
Norris, Murray D;
Henderson, Michelle J

Publication type:

Article

The outcomes of intestinal resection during debulking surgery for ovarian cancer.

Published in:

Turkish Journal of Surgery (Turkish Surgical Association), 2017, v. 33, n. 2, p. 96, doi. 10.5152/UCD.2016.3515

By:

Terzioğlu, Serdar Gökay;
Kılıç, Murat Özgür;
Çetinkaya, Nilüfer;
Baser, Eralp;
Güngör, Tayfun;
Adıgüzel, Cevdet

Publication type:

Article

Bevacizumab-Based Chemotherapy Triggers Immunological Effects in Responding Multi-Treated Recurrent Ovarian Cancer Patients by Favoring the Recruitment of Effector T Cell Subsets.

Published in:

Journal of Clinical Medicine, 2019, p. 380, doi. 10.3390/jcm8030380

By:

Napoletano, Chiara;
Ruscito, Ilary;
Bellati, Filippo;
Zizzari, Ilaria Grazia;
Rahimi, Hassan;
Gasparri, Maria Luisa;
Antonilli, Morena;
Panici, Pierluigi Benedetti;
Rughetti, Aurelia;
Nuti, Marianna

Publication type:

Article

ABCB1 Variation Affects Myelosuppression, Progression‐free Survival and Overall Survival in Paclitaxel/Carboplatin‐treated Ovarian Cancer Patients.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2018, v. 123, n. 3, p. 277, doi. 10.1111/bcpt.12997

By:

Björn, Niclas;
Jakobsen Falk, Ingrid;
Gréen, Henrik;
Vergote, Ignace

Publication type:

Article

CX-5461 can destabilize replication forks in PARP inhibitor-resistant models of ovarian cancer.

Published in:

Molecular & Cellular Oncology, 2020, v. 7, n. 6, p. 1, doi. 10.1080/23723556.2020.1805256

By:

Xuan, Jiachen;
Pearson, Richard B.;
Sanij, Elaine

Publication type:

Article

SOX2 is a promising predictor of relapse and death in advanced stage high-grade serous ovarian cancer patients with residual disease after debulking surgery.

Published in:

Molecular & Cellular Oncology, 2020, v. 7, n. 6, p. 1, doi. 10.1080/23723556.2020.1805094

By:

Bååth, Maria;
Westbom-Fremer, Sofia;
Martin de la Fuente, Laura;
Ebbesson, Anna;
Davis, Juliette;
Malander, Susanne;
Måsbäck, Anna;
Kannisto, Päivi;
Hedenfalk, Ingrid

Publication type:

Article

Immunonutrition in the perioperative period of ovarian cancer: from molecular mechanism to clinical application.

Published in:

European Journal of Gynaecological Oncology, 2025, v. 46, n. 4, p. 1, doi. 10.22514/ejgo.2025.045

By:

Feiyang Li;
Linjuan Cai;
Juan Mu;
Chen Jiang;
Yue Wu;
Xuyao Xu;
Haiyan Chen;
Dake Li;
Jian Cao

Publication type:

Article

Diagnostic challenges of ovarian hemangioma: a case report.

Published in:

European Journal of Gynaecological Oncology, 2025, v. 46, n. 3, p. 117, doi. 10.22514/ejgo.2025.044

By:

Hyun Kyung Ryu;
Nah Ihm Kim;
Moon Kyoung Cho;
Chul Hong Kim

Publication type:

Article

Association of ultrasound findings with hematological parameters, cytokines and survival in ovarian cancer.

Published in:

European Journal of Gynaecological Oncology, 2025, v. 46, n. 3, p. 27, doi. 10.22514/ejgo.2025.033

By:

Simões Nomelini, Rosekeila;
Soares Tamburús, Murilo Luiz;
Arvelos Crispim, Paula Carolina;
Martins Filho, Agrimaldo;
Prata Jammal, Millena;
Cobo Micheli, Douglas;
Candido Murta, Eddie Fernando

Publication type:

Article

Trabectedin-pegylated liposomal doxorubicin compared to cisplatin desensitization regimen-paclitaxel in ovarian cancer patients.

Published in:

European Journal of Gynaecological Oncology, 2024, v. 45, n. 6, p. 32, doi. 10.22514/ejgo.2024.114

By:

Paulsen, Torbjørn;
Birgisdottir, Alda;
Myklebust, Tor Åge;
Dørum, Anne;
Zahl Eriksson, Ane Gerda;
Vilming, Bente

Publication type:

Article

Next generation sequencing analysis of BRCA1/2 genes reveals clinically significant pathogenic mutations in ovarian cancer patients.

Published in:

European Journal of Gynaecological Oncology, 2024, v. 45, n. 3, p. 75, doi. 10.22514/ejgo.2024.051

By:

Yang Gao;
Shengqi Su;
Naz, Rida;
Xufei Yao

Publication type:

Article

Difficulties and inequities in access to homologous recombination deficiency testing in ovarian cancer patients.

Published in:

European Journal of Gynaecological Oncology, 2024, v. 45, n. 3, p. 1, doi. 10.22514/ejgo.2024.042

By:

Barberis, Massimo

Publication type:

Article

Comments on the definition of ovarian cancer stage IC2, related to fertility-sparing treatment.

Published in:

European Journal of Gynaecological Oncology, 2023, v. 44, n. 6, p. 157, doi. 10.22514/ejgo.2023.111

By:

Şerban, Nastasia;
Ana-Cătălina, Savu;
Camelia, Duţescu

Publication type:

Article

Adjuvant chemotherapy is not associated with improved overall survival with stage I endometrioid ovarian cancer patients in a SEER cohort.

Published in:

European Journal of Gynaecological Oncology, 2022, v. 43, n. 6, p. 53, doi. 10.22514/ejgo.2022.058

By:

Ruonan Mao;
Jiawei Li;
Mingming Sun;
Jun Li;
Wei Jiang

Publication type:

Article

Review of neoadjuvant chemotherapy characteristics in advanced epithelial ovarian cancer: experience from two cancer centers.

Published in:

European Journal of Gynaecological Oncology, 2022, v. 43, n. 4, p. 25, doi. 10.22514/ejgo.2022.021

By:

Ferreira da Silva, Filipa;
Baptista de Almeida, Susana;
de Lurdes Batarda, Maria;
Braga, Sofia;
Nabais, Henrique

Publication type:

Article

A review of robotic surgery in the management of recurrent ovarian carcinoma: indication and techniques.

Published in:

European Journal of Gynaecological Oncology, 2022, v. 43, n. 4, p. 1, doi. 10.22514/ejgo.2022.030

By:

Lim, Peter C.

Publication type:

Article

BRCA screening, treatment patterns and response among patients with ovarian cancer in the second line treatment setting: results from a real world survey.

Published in:

European Journal of Gynaecological Oncology, 2022, v. 43, n. 2, p. 202, doi. 10.31083/j.ejgo4302026

By:

Monberg, Matthew J.;
Hall, Jennifer P.;
Moon, Rebecca;
Khela, Keerun;
McLaurin, Kimmie

Publication type:

Article

Quality of life in ovarian cancer patients receiving chemotherapy--preliminary study.

Published in:

European Journal of Gynaecological Oncology, 2021, v. 42, n. 6, p. 1180, doi. 10.31083/j.ejgo4206172

By:

Różycka, Mariola;
Plagens-Rotman, Katarzyna;
Trusz, Wojciech;
Jarząbek-Bielecka, Grażyna;
Merks, Piotr

Publication type:

Article

The clinical outcomes of ovarian cancer in patients with brain metastasis.

Published in:

European Journal of Gynaecological Oncology, 2021, v. 42, n. 5, p. 881, doi. 10.31083/j.ejgo4205134

By:

Simsek, Seda Yuksel;
Guler, Ozan Cem;
Durdag, Gülşen Doğan;
Sari, Sezin Yüce;
Gultekin, Melis;
Yildiz, Ferah;
Celik, Husnu;
Erbay, Gurcan;
Onal, Huseyin Cem

Publication type:

Article

Effectiveness of human epididymis protein 4 (HE4) as predictor of response to first line platinum based chemotherapy.

Published in:

European Journal of Gynaecological Oncology, 2021, v. 42, n. 5, p. 844, doi. 10.31083/j.ejgo4205129

By:

Francesco, Plotti;
Martina, Bartolone;
Corrado, Terranova;
Federica, Guzzo;
Nardone Carlo, De Cicco;
Roberto, Montera;
Michele, Molinaro;
Massimo, Ciccozzi;
Domenico, Benvenuto;
Violante, Di Donato;
Panici Pierluigi, Benedetti;
Roberto, Angioli

Publication type:

Article

Bevacizumab for malignant pleural effusion in ovarian clear cell carcinoma: a case report.

Published in:

2021

By:

Di Wu;
Yanqin Zhang;
Jinwei Miao

Publication type:

Case Study

Early initiation of chemotherapy after primary surgery as an adverse prognostic factor in patients with ovarian cancer.

Published in:

European Journal of Gynaecological Oncology, 2019, v. 40, n. 2, p. 236, doi. 10.12892/ejgo4363.2019

By:

Bodnar, L.;
Knapp, P.;
Sznurkowski, J.;
Mądry, R.;
Gąsowska-Bodnar, A.;
Sikorska, M.;
Timorek, A.;
Ptak-Chmielewska, A.;
Jach, R.

Publication type:

Article

Chemotherapy improves survival rate in Stage 1 ovarian cancers.

Published in:

European Journal of Gynaecological Oncology, 2018, v. 39, n. 1, p. 49, doi. 10.12892/ejgo3715.2018

By:

Dewick, L.;
Raut, J.;
Asher, V.

Publication type:

Article

The prognostic role of circulating tumor cells and disseminated tumor cells in patients with ovarian cancer: a systematic review and meta-analysis.

Published in:

European Journal of Gynaecological Oncology, 2017, v. 38, n. 4, p. 504, doi. 10.12892/ejgo3396.2017

By:

Zeng, C.;
Zhang, X. Q.;
Fan, W. D.;
Ting, T.

Publication type:

Article

Vascular endothelial growth factor (VEGF) and cyclooxygenase 2 (COX 2) immunostaining in ovarian cancer.

Published in:

European Journal of Gynaecological Oncology, 2016, v. 37, n. 2, p. 164, doi. 10.12892/ejgo2705.2016

By:

Whynott, R. M.;
Manahan, K. J.;
Geisler, J. P.

Publication type:

Article

Surgical Stage I high-grade ovarian cancer: is adjuvant chemotherapy warranted?

Published in:

European Journal of Gynaecological Oncology, 2015, v. 36, n. 6, p. 633, doi. 10.12892/ejgo2709.2015

By:

Segev, Y.;
Ismiil, N.;
McVey, R.;
Covens, A.

Publication type:

Article

Effectiveness of third-line chemotherapy in recurrent ovarian cancer patients.

Published in:

European Journal of Gynaecological Oncology, 2015, v. 36, n. 4, p. 424, doi. 10.12892/ejgo2646.2015

By:

Yoshihama, T.;
Chiyoda, T.;
Kataoka, F.;
Nomura, H.;
Iguchi, Y.;
Hashimoto, S.;
Yamagami, W.;
Tominaga, E.;
Susumu, N.;
Tsuda, H.;
Aoki, D.

Publication type:

Article

Disease-free ovarian cancer patients report severe pain and fatigue over time: prospective quality of life assessment in a consecutive series.

Published in:

European Journal of Gynaecological Oncology, 2015, v. 36, n. 2, p. 155, doi. 10.12892/ejgo2585.2015

By:

Shinde, S.;
Wanger, T.;
Novotny, P.;
Grudem, M.;
Jatoi, A.

Publication type:

Article

Comparison between the effect of epidural anesthesia combined with epidural analgesia and general anesthesia combined with intravenous analgesia on prognosis of ovarian cancer patients.

Published in:

Oncology Letters, 2019, v. 17, n. 6, p. 5662

By:

Zhong, Shuigen;
Zhong, Xiaoxue;
Zhong, Xiaomei;
Liu, Yanlong

Publication type:

Article

MicroRNA profiling of plasma exosomes from patients with ovarian cancer using high-throughput sequencing.

Published in:

Oncology Letters, 2019, v. 17, n. 6, p. 5601

By:

Zhang, Honghong;
Xu, Sijuan;
Liu, Xiaoli

Publication type:

Article

Comparison of diagnostic values between CA125 combined with CA199 and ultrasound combined with CT in ovarian cancer.

Published in:

Oncology Letters, 2019, v. 17, n. 6, p. 5523

By:

Guo, Bingcheng;
Lian, Wei;
Liu, Shuai;
Cao, Yingchun;
Liu, Jianhua

Publication type:

Article

Effect of dexmedetomidine anesthesia on perioperative levels of TNF-α and IL-6 in patients with ovarian cancer.

Published in:

Oncology Letters, 2019, v. 17, n. 6, p. 5517

By:

Liu, Maodong;
Yi, Yusheng;
Zhao, Mingqiang

Publication type:

Article

Expression and clinical significance of SLP-2 in ovarian tumors.

Published in:

Oncology Letters, 2019, v. 17, n. 5, p. 4626

By:

Zhang, Jingjing;
Song, Xiucai;
Li, Cuihong;
Tian, Yanjie

Publication type:

Article

Influence of obesity on surgical complications of patients with ovarian tumors.

Published in:

Oncology Letters, 2019, v. 17, n. 5, p. 4590

By:

Lv, Huimin;
Wu, Suhui

Publication type:

Article

Expression of miR-26b in ovarian carcinoma tissues and its correlation with clinicopathology.

Published in:

Oncology Letters, 2019, v. 17, n. 5, p. 4417

By:

Lu, Jianjun;
Zhang, Wei;
Ding, Yang;
Li, Xiang;
Song, Jiandong

Publication type:

Article

Combinatorial therapy of immune checkpoint and cancer pathways provides a novel perspective on ovarian cancer treatment.

Published in:

Oncology Letters, 2019, v. 17, n. 3, p. 2583

By:

Zhang, Guyu;
Liu, Chongdong;
Bai, Huiming;
Cao, Guangming;
Cui, Ran;
Zhang, Zhengyu

Publication type:

Article

MicroRNA-19b promotes the migration and invasion of ovarian cancer cells by inhibiting the PTEN/AKT signaling pathway.

Published in:

Oncology Letters, 2018, v. 16, n. 1, p. 559, doi. 10.3892/ol.2018.8695

By:

Liu, Dan-Tong;
Yao, Hai-Rong;
Li, Yan-Ying;
Song, Yang-Yang;
Su, Meng-Ya

Publication type:

Article

Loss of beclin 1 expression in ovarian cancer: A potential biomarker for predicting unfavorable outcomes.

Published in:

Oncology Letters, 2018, v. 15, n. 1, p. 1170, doi. 10.3892/ol.2017.7379

By:

Minamoto, Toshiko;
Nakayama, Kentaro;
Nakamura, Kohei;
Katagiri, Hiroshi;
Sultana, Razia;
Ishibashi, Tomoka;
Ishikawa, Masako;
Yamashita, Hitomi;
Sanuki, Kaori;
Iida, Kouji;
Nakayama, Satoru;
Otsuki, Yoshiro;
Ishikawa, Noriyuki;
Kyo, Satoru

Publication type:

Article

Effective treatment of a patient with stage IV ovarian cancer: A case report.

Published in:

2018

By:

Huang, Zhen;
Yan, Hua;
Chavan, Devendra;
Yuan, Zeng;
Yang, Xingsheng;
Zhang, Youzhong;
Song, Kun;
Kong, Beihua

Publication type:

Case Study

Metformin in combination with cisplatin inhibits cell viability and induces apoptosis of human ovarian cancer cells by inactivating ERK 1/2.

Published in:

Oncology Letters, 2017, v. 14, n. 6, p. 7557, doi. 10.3892/ol.2017.7176

By:

Jian‑hong Dang;
Zhi‑jun Jin;
Xiao‑jun Liu;
Dian Hu;
Jing Wang;
Yan Luo;
Ling‑ling Li

Publication type:

Article

MiR‑124 inhibits invasion and induces apoptosis of ovarian cancer cells by targeting programmed cell death 6.

Published in:

Oncology Letters, 2017, v. 14, n. 6, p. 7311, doi. 10.3892/ol.2017.7157

By:

Li Yuan;
Shaolin Li;
Qi Zhou;
Dong Wang;
Dongling Zou;
Jin Shu;
Yu Huang

Publication type:

Article

Clinical and biological effects of tumor-associated lymphocytes in the presence or absence of chemotherapy for malignant ascites in ovarian cancer patients.

Published in:

Oncology Letters, 2017, v. 14, n. 3, p. 3379, doi. 10.3892/ol.2017.6635

By:

Weiwei Zhang;
Kejun Liu;
Bin Ye;
Guolin Hu;
Kelei Zhao;
Yazhou Ren;
Weijiang Liang

Publication type:

Article

Expression of miR-146a in patients with ovarian cancer and its clinical significance.

Published in:

Oncology Letters, 2017, v. 14, n. 3, p. 3207, doi. 10.3892/ol.2017.6477

By:

Wilczyński, Miłosz;
Żytko, Ewelina;
Szymańska, Bożena;
Dzieniecka, Monika;
Nowak, Marek;
Danielska, Justyna;
Stachowiak, Grzegorz;
Wilczyński, Jacek R.

Publication type:

Article

PARP-1 may be involved in angiogenesis in epithelial ovarian cancer.

Published in:

Oncology Letters, 2016, v. 12, n. 6, p. 4561, doi. 10.3892/ol.2016.5226

By:

WEI WEI;
YAN LI;
SHUQING LV;
CANCAN ZHANG;
YONGJIE TIAN

Publication type:

Article